Research Update

CAPRISA News Building capacity for Namibian ScientistsChanges in CAPRISA’s HIV Vaccine and Pathogenesis Research ProgrammeField Dot Outreach InitativeOutstanding achievement by CAPRISA fellowInvestigating the role of APOBEC3G expression during HIV infection, was published recently in the journal AIDS.Microbicide Trials Network, Cape Town meeting

CAPRISA Menu

Resources

Did you find this site useful with respect to HIV/AIDS research in South Africa?

	Yes
	No
	Requires more content.
	Requires a Discussion Forum.

Subscription

Designed by:

PDF

Print

E-mail

Research Update - November/December 2009

Study	Site	Screened	Screened	No. Enrolled	No. Enrolled
		Total	Cumulative	Total	Cumulative
Acute Infection	Umbilo (phase II)	0	62	0	62
CAT	Vulindlela	28	3457	24	1478
CAT	eThekwini	56	2340	19	893
SAPIT	eThekwini	-	1364	-	642*
START	eThekwini	0	147	-	58*
CHAVI	eThekwini	0	10852	0	32*
HEPS	Umbilo	-	-	0	122*
HVTN	eThekwini	-	114	-	53*
Microbicide	eThekwini	10	1050	0	280*
Microbicide	Vulindlela	0	1110	0	620*
EASP	eThekwini	-	-	-	298*
ACTG	eThekwini	0	107*	0	40*
TRAPS	eThekwini & Vulindlela	2	90	2	90
*enrollment stopped

Content View Hits : 4927949